• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Theravance Inc. (THRX)

    -NasdaqGS
    16.87 Down 0.55(3.16%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:17.42
    Open:17.50
    Bid:16.00 x 500
    Ask:N/A
    1y Target Est:14.20
    Beta:3.33
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:16.76 - 17.50
    52wk Range:10.58 - 30.56
    Volume:672,143
    Avg Vol (3m):623,564
    Market Cap:1.97B
    P/E (ttm):N/A
    EPS (ttm):-0.98
    Div & Yield:1.00 (5.20%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    THRXDown 3.16%1.97B
    AZNUp 1.19%82.68B
    PFEDown 0.95%205.48B

    Key Statistics

    Forward P/E (1 yr):33.74
    P/S (ttm):126.38
    Ex-Dividend Date:10-Jun-15

    Analysts

    Annual EPS Est (Dec-15) :-0.15
    Quarterly EPS Est (Jun-15) :-0.06
    Mean Recommendation*:3.2
    PEG Ratio (5 yr expected):0.67

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback